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Linkage evidence suggests that chromosome 13 (13q32-33) contains susceptibility genes for both bipolar disorder and
schizophrenia. Recently, genes called “G72” and “G30” were identified, and polymorphisms of these overlapping
genes were reported to be associated with schizophrenia. We studied two series of pedigrees with bipolar disorder:
the Clinical Neurogenetics (CNG) pedigrees (in which linkage to illness had been previously reported at 13q32-33),
with 83 samples from 22 multiplex families, and the National Institute of Mental Health (NIMH) Genetics Initiative
pedigrees, with 474 samples from 152 families. Sixteen single-nucleotide polymorphisms (SNPs) were genotyped at
and around the G72/G30 locus, which covered a 157-kb region encompassing the entire complementary DNA
sequences of G72 and G30. We performed transmission/disequilibrium testing (TDT) and haplotype analysis, since
a linkage-disequilibrium block was present at this gene locus. In the CNG and NIMH data sets, the results of global
TDT of the entire haplotype set were significant and consistent ( and , respectively). In the CNGPp .0004 Pp .008
series, the associated genotypes divided the families into those with linkage and those without linkage (partitioned
by the linkage evidence). Analysis of the decay of haplotype sharing gave a location estimate that included G72/G30
in its 95% confidence interval. Although statistically significant association was not detected for individual SNPs in
the NIMH data set, the same haplotype was consistently overtransmitted in both series. These data suggest that a
susceptibility variant for bipolar illness exists in the vicinity of the G72/G30 genes. Taken together with the earlier
report, this is the first demonstration of a novel gene(s), discovered through a positional approach, independently
associated with both bipolar illness and schizophrenia.
Introduction
Bipolar disorder is a common disease with a lifetime
prevalence rate of 1% and involves episodic distur-
bances of mood, sleep, appetite, and other physiolog-
ical functions. Although a single gene may occasion-
ally have a major effect in some families, multiple
genes and environmental factors are generally consid-
ered to play roles in the development of bipolar dis-
order (Craddock and Jones 1999). Two chromosomal
regions—13q32-33 and 22q11—have been found to
confer susceptibility, by meta-analysis of genomewide
linkage studies (Badner and Gershon 2002). In that
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analysis, the same two regions were significantly
linked to schizophrenia (MIM 181500). This result
suggests the possibility that, in these chromosomal
regions, there are shared genes predisposing to these
psychiatric illnesses (Berrettini 2000; Gershon 2000).
On 13q32-33, there had been no gene whose asso-
ciation with major psychiatric illnesses was significant
until genes called “G72” and “G30” were recently iden-
tified in a 65-kb region where there is evidence of as-
sociation with schizophrenia (Chumakov et al. 2002).
These two genes overlap on complementary chromo-
somal strands. On the basis of the integrated physical
map of this region (Christian et al. 2002), these genes
are located ∼90 cM from the short-arm telomere of
chromosome 13, where there had been no known genes.
Significant association with schizophrenia was found in
several SNPs and haplotypes at this locus in a case-
control study analyzing French-Canadian samples, with
the association of two SNPs being replicated in a Rus-
sian cohort. They also performed expression and func-
tional studies of these genes. The G72 gene was sug-
gested to interact with D-amino-acid oxidase and to
exert an effect on the regulation of D-serine, an agonist
1132 Am. J. Hum. Genet. 72:1131–1140, 2003
for the glycine-binding site of the N-methyl-D-aspartate–
type glutamate receptor, whereas the function of the
G30 gene remained unclear.
Since linkage to 13q32-33 was the most significant
finding across the entire genome in this pedigree series
with bipolar disorder in previous studies (Detera-Wad-
leigh et al. 1999; C. Liu et al. 2001), we examined the
G72/G30 gene locus for possible association with bipo-
lar disorder by analysis of the same pedigree series along
with an additional independent pedigree series with bi-
polar disorder. We performed transmission/disequilib-
rium testing (TDT) (Spielman et al. 1993), for individual
SNPs and haplotypes, and two recently developed anal-
yses: partitioning of linkage evidence according to ge-
notype (Horikawa et al. 2000) and decay of haplotype
sharing (DHS) (McPeek and Strahs 1999). In addition,




We studied two pedigree series with bipolar illness.
One of them, the Clinical Neurogenetics (CNG) ped-
igrees, with 371 individuals from 22 extended multi-
plex families, has been described elsewhere (Berrettini
et al. 1991). The initial genome scan and the subse-
quent fine mapping of 13q32-33 detected the strongest
evidence of linkage around D13S779-D13S225 (LOD
score 3.25 [ ]), by multipoint linkage anal-Pp .000546
ysis with Aspex and Genehunter Plus in nuclear fam-
ilies, whereas linkage was not significant when all 371
individuals were analyzed by Genehunter in extended
pedigrees (Detera-Wadleigh et al. 1999; C. Liu et al.
2001). This discrepancy can result from a common sus-
ceptibility allele, as discussed elsewhere (Badner et al.
1998). Consequently, in the present study, we selected
83 individuals for genotyping, so that each extended
family is represented by one nuclear family with parents
and one or two affected offspring. Sib pairs with in-
creased sharing for markers at 13q32 were preferen-
tially selected, when possible, to enhance the likelihood
that they would carry the susceptibility locus. In this
series, significant linkage disequilibrium (LD) was ob-
served by TDT at marker D13S280 (C. Liu et al. 2001),
which is 2.8 Mb proximal to the G72 locus. Another
series, the National Institute of Mental Health (NIMH)
Genetics Initiative pedigrees, has been described in de-
tail elsewhere (Nurnberger et al. 1997), and evidence
of linkage had been nominally significant at 13q in the
initial genome scan (Stine et al. 1997) but was no longer
significant (although positive) after the number of sam-
ples was increased, reaching 474 individuals in 152
families in the present study (data not shown). As in
the first series, sib pairs with increased sharing for
markers in the 13q32 region were preferentially se-
lected when possible. These two series predominantly
consisted of individuals of European descent and in-
cluded patients with bipolar I disorder, bipolar II dis-
order, schizoaffective disorder, and recurrent depression.
SNP Selection and Genotyping
SNP-Cruncher software (C. Liu and Gershon 2001)
was used to collect SNP data around the G72/G30
gene locus from the public databases, including the
National Center for Biotechnology (see the dbSNP
Home Page), the SNP Consortium, and the Human Ge-
nome Browser Gateway (see the UCSC Genome Bioin-
formatics Web site). With the tools provided in SNP-
Cruncher, we selected SNPs suitable for genotyping by
filtering out repeat sequences, removing possible dupli-
cations of SNPs in the databases, checking the validation
status, and searching for restriction enzymes that rec-
ognize each polymorphism. All discovered SNPs, STSs,
and ESTs and the G72/G30 genes were mapped to a
reference genomic DNA sequence by DNannotator.
This sequence was assembled and evaluated locally and
is nearly identical to part of the sequence in GenBank
(accession numbers NT_009952.10, AE014312, and
AE014313). SNPs were then selected for genotyping,
considering factors such as minor-allele frequency (if
available), distance from the G72/G30 genes, marker
intervals, and availability of inexpensive restriction en-
zymes for genotyping.
Initially, six SNPs (rs1935058, rs1341402, rs2391191,
rs1935062, rs947267, and rs954581) close to or at the
G72/G30 gene locus were genotyped and tested for as-
sociation by analysis of the CNG pedigree series. After
finding significant association between five of these SNPs
and illness either by TDT or by partitioning of linkage
evidence (as described below, in the “Results” section),
we also genotyped these six markers for analysis in the
NIMH pedigree series. Also, to delimit the range of as-
sociation by fine mapping of a 157-kb region surrounding
the G72/G30 genes, we added eight SNPs (rs1998654,
rs2181953, rs978714, rs1359387, rs1815686, rs778294,
rs778334, and rs2012887) from the public databases and
two SNPs (M-13 and M-23) described elsewhere (Chu-
makov et al. 2002). We typed all of these additional 10
markers in the CNG series but only 1 (rs778294) in the
NIMH series, because it did not seem to be suitable for
the purpose of delimiting the region of association, as
described in the “Discussion” section.
Fragments containing the selected SNPs were ampli-
fied by PCR with primers designed by Primer3 software
(Rozen and Skaletsky 2000). Of all 16 SNPs, 13 were
genotyped by RFLPs, whereas SNPs rs2391191, M-13,
and M-23 were typed by direct sequencing of PCR prod-
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Table 1
TDT by Locus and Partitioning of Linkage Evidence According to Genotype












nd LODe nd LOD (P)e nd LODe
CNG pedigrees:
rs1998654 CT T .0 1 .38 18 2.87 9 .1 0 0
rs2181953 AT T 27.8 .39 .47 11 2.59 9 .5 7 .07
rs978714 AG G 38.3 .62 .67 9 .73 15 .7 3 2.44
rs1359387 AG A 43.3 .53 .65 10 .36 12 1.46 5 .92
rs1815686 CG C 80.6 .041 .93 12 .11 9 2.62 (.016) 6 .6
M-13 AC C 82.1 .11 .81 11 .01 8 2.48 (.02) 8 1.32
rs1935058 CT C 82.5 .00077 1.00 14 .39 7 2.01 (.042) 6 .6
rs1341402 CT T 86.7 .0075 .80 19 .85 8 2.08 (.046) 0 0
rs2391191f AG A 90.6 .08 .84 11 .01 8 2.48 (.02) 8 1.32
rs1935062 AC A 99.3 .0078 .11 7 .4 12 2.8 (.027) 8 .07
rs947267f AC A 110.8 .17 .70 13 .05 11 3.63 (.0042) 3 .42
rs778294f AG G 113.4 .018 .83 20 1.03 7 1.9 (.05) 0 0
rs954581 CT T 123.4 .62 .57 19 2.99 7 .04 1 0
rs778334 TC T 131.1 .8 .50 2 .61 5 .03 20 2.22
rs2012887 CT C 141.1 .17 .58 10 1.17 12 1.05 5 .33
M-23 CT C 156.8 .074 .38 5 .33 11 .54 11 1.87
NIMH pedigrees:
rs1935058 CT C 82.5 .055 .63 38 .06 69 .14 42 .00
rs1341402 CT T 86.7 .58 .56 87 .01 54 .00 8 -0.01
rs2391191f AG A 90.6 .39 .57 29 .00 68 .06 52 .00
rs1935062 AC A 99.3 .38 .43 60 .05 66 .00 23 .00
rs947267f AC A 110.8 .58 .48 50 .00 68 .11 31 .05
rs778294f AG G 113.4 .24 .61 80 .11 53 .14 15 .11
rs954581 CT T 123.4 .11 .65 114 .06 33 .47 2 .10
a SNPs are ordered from the centromere to the telomere of 13q.
b Positions of SNPs are shown as distances from rs1998654, where ranges of G72 and G30 are 89.4–114.5 kb and 82.6–129.2 kb, respectively.
c Frequency with which allele 1 is transmitted from a heterozygous parent to an affected offspring.
d Number of probands for each genotype.
e Calculated for a group of families with probands that have each specific genotype, testing for difference of linkage scores among the separate
groups of families (Horikawa et al. 2000). P values !.05 are omitted.
f SNPs rs2391191, rs947267, and rs778294 correspond to M-15, M-18, and M-19, respectively, of Chumakov et al. (2002).
ucts with an automated sequencer (ABI 3700 DNA an-
alyzer; Applied Biosystems). The SNPs, along with their
positions, are given in table 1.
Genotyping results were examined for incompatibil-
ities within families, by PedCheck (O’Connell and Weeks
1998), and also for unlikely recombinations, by Merlin
(Abecasis et al. 2002). Detection of incompatibilities or
unlikely recombinants led to rechecking of genotypes
and subsequent correction as necessary. None of the
SNPs deviated from Hardy-Weinberg equilibrium in ei-
ther of the pedigree series.
Statistical Analyses
TDT by individual SNP locus was performed using
the Aspex/SibTDT program, which tests for LD in sib-
ships, controlling for evidence of linkage. Empirical
probabilities for x2 statistics are calculated, which will
accurately reflect association independently of linkage
within families. This calculation is done by permuting
the parent alleles while fixing the IBD status of sibs
within a family. Transmission and frequencies of hap-
lotypes were analyzed by TDTPhase (Dudbridge et al.
2000), using the “tsu” correction for sib pairs, which
controls for the presence of linkage. This correction
includes only parents transmitting the same haplotype
to all sibs. When one or more sibs are ambiguous, only
the first sib is included in the analysis. In the calculation
of the global tests, haplotypes with counts !5 were
dropped. In TDT, the transmission ratio for one ran-
domly chosen individual per sibship was also calculated
for each allele and haplotype. The transmission ratio
was estimated as the frequency with which an allele or
haplotype is transmitted from a heterozygous parent
to an affected offspring.
We also tested partitioning evidence of linkage accord-
ing to genotype, as described elsewhere (Horikawa et al.
2000). Positive results obtained using this test are re-
garded as further evidence of association. In the present
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Figure 1 Frequencies for each SNP—and LD between pairs of loci. The diagonal pattern composed of blue boxes represents the minor-
allele frequencies of each SNP in the CNG pedigrees. To either side of the diagonal are the P values for LD between pairs of loci in the CNG
and NIMH pedigrees, respectively; significant LD ( ) is shown in yellow. In the NIMH series, an LD block extended across the entireP ! .05
region examined between rs1935058 and rs954581.
analysis, 22 and 152 probands were randomly selected
from the CNG and NIMH series, respectively, and fam-
ilies were separated into groups according to the geno-
types of probands for each SNP. If there was no associ-
ation between the SNP and the evidence for linkage, the
resulting LOD score within each genotype group should
be proportional to the number of families within that
group. If there is association, the LOD score should be
disproportionately high within one or two of the genotype
groups. Linkage score for each group was calculated on
the basis of the original linkage evidence at 13q32-33 in
the CNG series, as demonstrated by the Genehunter Plus
(Kong and Cox 1997) analysis in nuclear families by use
of the narrow affection model (Detera-Wadleigh et al.
1999; C. Liu et al. 2001), and in the NIMH series (data
not shown). Families in which the proband contained
the SNP genotype being tested were weighted 1, whereas
other families were weighted 0. If there was more than
one nuclear family within a pedigree, then all were weight-
ed the same on the basis of the proband’s genotype. Em-
pirical P values, for the assessment of the significance of
the increase in the LOD score for the group defined by
SNP genotype, were obtained by randomly choosing the
same number of families included in the group generating
the increased LOD score by use of Weight (N. J. Cox,
personal communication). Enough replicates were simu-
lated until 20 replicates achieving a LOD score at least
as high as that observed in the genotype group were
generated.
DHS analysis as implemented in DHSMap (McPeek
and Strahs 1999) was also performed, to plot the like-
lihood of association for the entire 157-kb region and
to delimit the 95% CI of association. Haplotypes from
a single randomly selected proband in each pedigree
from the CNG data set were used. The transmitted
haplotypes were considered as the “cases,” and the
nontransmitted haplotypes were considered as the
“controls.” The conditional-coalescent model was
used. All analyses were based on one affection status
model, wherein the definition of affected category was
restricted to bipolar I, bipolar II with major depres-
sion, and schizoaffective disorder.
Results
Pairwise LD
To calculate the P value for LD between pairs of
loci, we used genotypes from one individual per ped-
igree. Haplotypes that could be unambiguously in-
ferred from transmitted and nontransmitted geno-
types from the parents were estimated using software
written by our group (J. A. Badner, unpublished data).
P values of LD were calculated using Clump (Sham
and Curtis 1995). We present P values, rather than
D ′ values, because D ′ may be high but nonsignificant
owing to the absence of a low-frequency haplotype in
our small sample, thereby leading to spurious evidence
of LD. Although rs1341402 was not in significant LD
with adjacent markers in the CNG series, the number
of samples in this series did not seem to be large
enough to detect weak-to-moderate LD between loci.
The LD analysis in the NIMH series, with 152 sam-
ples, revealed that all seven SNPs between rs1935058
and rs778924 were in an LD block (fig. 1).
TDT
In the CNG series, significant LD with illness was
detected in three of the six SNPs that were initially
chosen because of their positions’ being close to or at












1112111 .25 .0003 .94 .30 .06 .60
2221221 .25 .008 .18 .25 .3 .44
2121111 .12 .1 .17
1121211 .09 .1 .83
2121112 .07 .7 .40 .08 .06 .32
2121211 .10 .1 .62
1111112 .06 .8 .43
2121221 .06 .04 .29
Global .0004 .008
a For each haplotype, alleles are concatenated according to the order rs1935058, rs1341402, rs2391191,
rs1935062, rs947267, rs778294, and rs954581. Haplotypes with a frequency !.05 are omitted.
b Frequency with which the haplotype is transmitted from a heterozygous parent to an affected offspring.
G72/G30 (table 1). The strongest association was de-
tected in rs1935058 ( ) (table 1). This SNPPp .00077
is 6.9 kb upstream of G72 exon 1 and 54 bp down-
stream of the last G30 exon on the opposite strand.
This SNP also showed near-significant association in
the NIMH series ( ). Although TDT gave noPp .055
P values !.05 for any SNPs in the NIMH series, trans-
mission ratios showed that the same alleles were con-
sistently over- or undertransmitted to affected offspring
in both series. When we looked at the subset of families
with increased evidence for linkage in the NIMH series
(Genehunter Plus nonparametric linkage score 10.7 for
the family), transmission ratios, in general, changed in
the direction expected (i.e., increased when 10.5 in the
total sample and decreased when !0.5 in the total sam-
ple). However, TDT was not significant, possibly owing
to the small sample size. SNP rs2391191 was the only
marker located in exons of either gene, and this variant
alters the amino acid sequence of the G72 protein as
presented by Chumakov et al. (2002) (although it would
be in the 5′ UTR of other transcripts, as described below,
in the “G72 and G30 cDNA Sequences” subsection).
However, no association was found between this mark-
er and bipolar disorder.
We then added 10 SNPs for genotyping in the CNG
series, to delineate the boundaries of association with
bipolar disorder. Among these, two showed significant
LD with illness (table 1). In all, 16 SNPs were genotyped
in the CNG pedigree series, and five of them were sig-
nificantly associated with illness. All five SNPs were close
to or at the G72/G30 genes.
We also analyzed the frequency of the haplotypes of
seven SNPs that are in disequilibrium with each other,
and we tested the transmission of the haplotypes in re-
lation to illness (table 2). The results showed that, in the
CNG series, the most common haplotype, 1112111, was
significantly overtransmitted ( ) and the secondPp .0003
most common haplotype, 2221221, which is almost the
mirror image of the first haplotype, was significantly un-
dertransmitted ( ) (table 2). The global TDT forPp .008
haplotype transmission gave significant results in both
the CNG series and the NIMH series ( andPp .0004
, respectively), with the most common haplo-Pp .008
type being overtransmitted to affected individuals in
both series.
Partitioning of Linkage Evidence
To obtain more evidence of association, we performed
another recently developed independent test: partition-
ing of linkage evidence (Horikawa et al. 2000). In the
CNG series, this test gave significant results in families
with heterozygous genotypes of eight consecutive SNPs
encompassing G72/G30, with the most significant P val-
ue !.0042 for rs947267 heterozygotes (table 1). All five
SNPs giving significant results in TDT were also signif-
icant in this test. In the NIMH series, we found no sig-
nificant partitioning of linkage evidence.
DHS
In this analysis, the likelihood of association reached
peak at the G72/G30 gene locus, giving a 95% CI of
association in a 78-kb region surrounding it (fig. 2). No
other genes are known in this interval. The haplotype
associated with bipolar disorder in this analysis is the
same as that in the TDTPhase analysis.
G72 and G30 cDNA Sequences
We have characterized cDNAs of G72 and G30, to
define the exons of these two genes so that one can assess
the functional significance of polymorphisms in the gene
region and to define potentially functional targets for
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Figure 2 Results from DHS analysis. Log-likelihood of association for each locus in the CNG pedigrees was plotted by the DHSMap
program. The horizontal axis shows the distance from rs1998654, the most proximal marker in the present study. Dots along the X-axis denote
the positions of SNPs whose genotypic data were used for this analysis. The ranges of all exons for G72/G30 are also shown with their 5′ to
3′ directions. This analysis gave a 95% CI of association in a 78-kb region encompassing the G72/G30 genes.
further polymorphism screening. The cDNAs have been
amplified, by PCR methods, from human testis and brain
cDNAs (Marathon Ready cDNA; Clontech) and occa-
sionally from fetal brain or amygdala cDNA. The two
genes appear to be expressed at quite low levels, since
it typically requires 40 cycles of PCR using 0.5–1.0 ng
of template to generate significant amounts of product,
whereas 30–35 cycles suffices for most other genes. This
low level of expression may contribute to the variability
as to which splice variants are observed in different PCRs
using the same template.
The G72 cDNA from human testis was initially ampli-
fied by rapid amplification of cDNA ends (RACE) PCR
and, subsequently, by PCR with gene-specific primers
from both ends. Different splice variants (GenBank ac-
cession numbers AY170469–AY170471) defined a total
of nine exons, implying that the exon structure is more
complicated than had been indicated by the GenBank
accession numbers (AY138546 and AY138547) sub-
mitted by Chumakov et al. (2002). Although our at-
tempts at RACE on brain cDNA were unsuccessful, we
did succeed in the amplification of products from adult
brain and fetal brain and amygdala (GenBank acces-
sion number AY223901) by using primers in exons 1
(TGCTGAATGGAAAGCCAGAAAGTAGAGTG) and
9 (GATTCTCCCAGTCACACAGGC). On the basis of
the products we have seen, transcripts typically contain
exons 1–3, 5, 8, and 9, with the variable inclusion of
exons 4, 6, and 7. In addition, intron 1 is frequently
retained, and exon 3 (exon N/N2 of Chumkov et al.)
and exon 8 use two alternative splice acceptors to pro-
duce long and short forms of the exon. The predicted
protein products are numerous, depending on which
exons are included—and, especially, on which splice
acceptor is used for exon 3, since the short form of
exon 3 permits the use of an initiation codon in exon
2 while the long form indicates the use of an initiation
codon in exon 5 (exon O of Chumkov et al.). In light
of both the variability we have seen as to which splice
variants are present in PCRs using different primer
pairs and the biases inherent in PCRs that select only
transcripts containing both primers, it is difficult to
assess which transcripts are the most significant. If the
gene encodes a protein of conserved function, then the
reported existence of frameshifts in exons 3 and 5 in
rhesus monkey, chimpanzee, and gorilla favors the use
of the initiation codon in exon 5.
The G30 cDNA as described in GenBank (accession
number AY138548) defines seven exons. Our preliminary
characterization of the G30 gene indicates that it is ex-
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pressed at levels as low as G72 is and that it contains at
least nine exons. PCRs using primers in exons 1 and 7
have given product with testis but not brain template.
These include transcripts that lack exon 4 and others that
contain an alternative exon 4. Furthermore, 5′ RACE re-
actions identify an alternative exon 5. Note that parts of
exons 4 and 5 are complementary to parts of G72 exons
8 and 2, respectively, which could lead to RNA interfer-
ence in cells expressing both transcripts.
Discussion
In the present study, we have examined the association
between the G72/G30 gene locus on 13q33 and bipolar
illness in two data sets, by two different tests for asso-
ciation—TDT, of individual SNPs and the global hap-
lotype of six SNPs, and partitioning of linkage evidence.
This is a family-based study and has the advantage of
avoiding false-positive results due to population strati-
fication, which could not be ruled out in the case-control
study of Chumakov et al. (2002). In the CNG series, the
latter gave eight consecutive SNPs at theG72/G30 locus,
with five of them being significant also in TDT. In the
NIMH series, the individual SNPs were not statistically
significant in either test. Bipolar disorder is thought to
be a heterogeneous illness, in which one susceptibility
gene could not account for the entire population of af-
fected subjects. The NIMH series, on the basis of weak
evidence of original linkage to the 13q32-33 region, may
contain a smaller proportion of families in which a var-
iant at or around G72/G30 is responsible for suscepti-
bility to illness, as compared to the CNG pedigrees. This
is also the reason why we included only the CNG series
for the purpose of delimiting the region of association by
DHS analysis. Still, the global TDT for haplotypes was
significant in both series, with the most common haplo-
type being consistently overtransmitted to affected off-
spring. Therefore, the two data sets are consistent with
each other, supporting association between this locus
and bipolar disorder.
Power analyses were performed to estimate the small-
est-effect gene that could be detected in each of the
pedigree series. Slink (Ott 1989; Weeks et al. 1990; Cot-
tingham et al. 1993) was used for the simulations. For
the simulations, data on pedigree structure, affection
status, and genotype at a single 13q32 marker were kept
the same as in the original series. A disease gene, with
allele frequency of 0.25 and varying degrees of multi-
plicative genotypic relative risks (MGRRs), and a SNP
marker, with allele frequency of 0.50, in complete LD
with the disease locus, and linked to the 13q32 marker,
were simulated. In the CNG series, for , thereP ! .05
was 80% power to detect a locus with MGRR 5, and
there was 50% power to detect a locus with MGRR 3.
In the NIMH series, for , there was 80% powerP ! .05
to detect a locus with MGRR 1.75, and there was 50%
power to detect a locus with MGRR 1.6. This is con-
sistent with the expectation that the effect of the locus
in the CNG series, a sample showing strong evidence of
linkage, would be larger than that in the NIMH series,
which does not show evidence of linkage (Go¨ring et al.
2001).
Partitioning of linkage evidence gave significant re-
sults in heterozygotes, rather than homozygotes, in eight
SNPs. There are several possible explanations for this
finding. For example, the number of homozygous pro-
bands was not large enough to detect significant par-
titioning of linkage evidence. Alternatively, there may
be an unknown biological mechanism for “heterosis,”
wherein heterozygotes are more likely to develop bipolar
disorder, as in the study of the calpain 10 gene and type
2 diabetes (Horikawa et al. 2000). The significant result
in this test supports the possibility that the original link-
age to 13q32-33 may be attributed to eitherG72 orG30.
However, since this locus is actually ∼3 cM away from
the distal edge of the 95% CI of linkage (Detera-Wadleigh
et al. 1999; C. Liu et al. 2001), the existence of another
susceptibility gene within the limits of this CI is still
plausible.
There has been considerable progress in the identifi-
cation of possible susceptibility genes for major psychi-
atric illnesses in chromosomal regions where linkage
with them was previously reported. Dysbindin, on 6p
(Straub et al. 2002), and neuregulin 1, on 8p (Stefans-
son et al. 2002), have been reported to be associated
with schizophrenia. On 22q11, a few genes have been
suggested for susceptibility to major psychiatric illness-
es. These genes include cathecol-O-methyltransferase
(COMT), PRODH2, and G-protein–coupled receptor
kinase 3 (GRK3) and are located within a range of a
microdeletion, which occurs with increased frequency
in schizophrenia. COMT has a long history of asso-
ciation reports in major psychiatric disorders, starting
with reports of different enzyme activities in patients
(Cohn et al. 1970). Although results from multiple stud-
ies of association between a functional polymorphism
at codon 108/158 (Val108/158 Met) of COMT and major
psychiatric illnesses are inconsistent, this polymorphism
has been suggested both to play a role in prefrontal
cognition impairment in schizophrenia (Egan et al.
2001) and to modify the course of rapid-cycling–type
bipolar disorder (Craddock et al. 2001). Also, a large-
scale case-control study showed association between
polymorphisms within the genomic sequence of the
COMT gene and schizophrenia, suggesting other sus-
ceptibility loci within this gene (Shifman et al. 2002).
Association between the PRODH2 gene and schizo-
phrenia has also been reported (H. Liu et al. 2002).
Expression level of GRK3 has been correlated with se-
verity of bipolar disorder (Niculescu et al. 2000). The
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different susceptibility associations on chromosome 22,
particularly for bipolar illness, remain to be resolved.
The G72/G30 gene locus, on 13q33, is one of the
few loci reported to be associated with both major
psychiatric illnesses that are present in regions where
linkage to both disorders has been consistently re-
ported (Badner and Gershon 2002). COMT is also
associated with both disorders, as noted above. These
findings are consistent with the speculation from the
linkage evidence that the same gene may be implicated
in both disorders (Berrettini 2000; Gershon 2000).
Do schizophrenia and bipolar disorder share a
common disease-susceptibility variant at the G72/
G30 locus? Since the range of the 95% CI of asso-
ciation given by DHS in the CNG series covered some
of the SNPs that Chumakov et al. (2002) had associ-
ated with schizophrenia, this remains possible; how-
ever, this range did not include two SNPs that were
associated with schizophrenia in both French-Cana-
dian and Russian data sets in their study. Obviously,
linkage or LD data do not tell which gene, G72 or
G30, confers susceptibility to each major psychiatric
illness. Chumakov et al. (2002), noting the absence of
a detectable in vitro translation product of the anti-
sense gene G30, have suggested transcriptional reg-
ulation of G72 by G30. The existence of multiple
splice variants of both genes, together with the pres-
ence of complementary segments in at least some of
these transcripts, provides the basis for a complex tran-
scriptional relationship between the two genes, but it
is unclear which gene regulates which. The present
evidence shows a bipolar association with the same
gene locus that had been associated with schizophrenia
(Chumakov et al. 2002) and may be considered as
supportive of a shared susceptibility-gene complex,
although possibly not of a shared variant or even a
shared gene.
In the haplotype analysis, two common haplotypes
were significant in the CNG series. This result implies
several possibilities. One of them is that the most com-
mon haplotype, 1112111, which is overtransmitted to
affected offspring, carries one or more predisposing
variants. Conversely, it is also possible that the un-
dertransmitted haplotype, 2221221, contains a variant
that is protective against the illness. In any case, the
susceptibility variant is expected to be frequent, on the
basis of associated haplotype frequencies and the pre-
vious finding, in the CNG series, that linkage to 13q32-
33 was more significant in the nuclear families than in
all extended families (Detera-Wadleigh et al. 1999; C.
Liu et al. 2001), given that power to detect evidence
of linkage in extended pedigrees can be less when a
causal variant is common (Badner et al. 1998). There-
fore, we could reasonably expect that intensive mu-
tational screening of the associated genomic region can
lead to detection of a susceptibility allele of bipolar
disorder. DHS analysis, although based on limited data
of randomly chosen probands from each CNG family
in the present study, provides a rational range in which
to search for such a susceptibility allele.
Acknowledgments
We thank all the patients and families included in this study.
Data and biomaterial were partly collected in four projects as
part of the NIMH Bipolar Disorder Genetics Initiative. From
1991 to 1998, the Principal Investigators and Co-Investigators
were as follows: Indiana University, Indianapolis.—John Nurn-
berger, M.D., Ph.D., Marvin Miller, M.D., and Elizabeth Bow-
man, M.D. (supported by grant U01 H46282); Washington
University, St. Louis.—Theodore Reich, M.D., Allison Goate,
Ph.D., and John Rice, Ph.D. (supported by grant U01
MH46280); Johns Hopkins University, Baltimore.—J. Ray-
mond DePaulo, Jr., M.D., Sylvia Simpson, M.D., M.P.H., and
Colin Stine, Ph.D. (supported by U01 H46274); NIMH In-
tramural Research Program, Clinical Neurogenetics Branch,
Bethesda.—Elliot Gershon, M.D., Diane Kazuba, B.A., and
Elizabeth Maxwell, M.S.W. This study was supported, in part,
by National Institutes of Health grants R01 MH65560-01 and
R01 MH59535 (both to E.S.G.), a National Alliance for Re-
search on Schizophrenia and Depression (NARSAD) Young
Investigator Award (to C.L.), a NARSAD Independent Inves-
tigator Award (to S.L.C.), a NARSAD Distinguished Investi-
gator Award (to E.S.G.), and a grant from Japan Foundation
for Aging and Health (to E.H.). Support from the Geraldi
Norton Memorial Corporation, the Eklund family, and Anita
Kaskel Roe is gratefully acknowledged. We also are grateful
to Dr. Hongwei Zou and Ms. Jennifer Lyons, both of whose
work on genotyping and sample management was invaluable,
and Dr. Takeo Yoshikawa, for critical advice on experiments.
Electronic-Database Information
The accession numbers and URLs for data presented herein
are as follows:
dbSNP Home Page, http://www.ncbi.nlm.nih.gov/SNP/
DNannotator, http://sky.bsd.uchicago.edu/DNannotator.htm
(for reference genomic DNA sequence)
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for our
G72 cDNA sequences [accession numbers AY170469–
AY170471 and AY223901], cDNA G72/G30 sequences of
Chumakov et al. [accession numbers AY138546–AY138548],
chromosome 13 reference genomic contig [accession number
NT_009952.10], andG72/G30 genomic sequences [accession
numbers AE14312 and AE14313])
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for schizophrenia)
SNP Consortium Ltd, The, http://snp.cshl.org/
UCSC Genome Bioinformatics, http://genome.ucsc.edu/ (for
Human Genome Browser Gateway)
Hattori et al.: Bipolar Disorder and the G72/G30 Genes 1139
References
Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002)
Merlin—rapid analysis of dense genetic maps using sparse
gene flow trees. Nat Genet 30:97–101
Badner JA, Gershon ES (2002) Meta-analysis of whole-genome
linkage scans of bipolar disorder and schizophrenia. Mol Psy-
chiatry 7:405–411
Badner JA, Gershon ES, Goldin LR (1998) Optimal ascertain-
ment strategies to detect linkage to common disease alleles.
Am J Hum Genet 63:880–888
Berrettini WH (2000) Are schizophrenic and bipolar disorders
related? A review of family and molecular studies. Biol Psy-
chiatry 48:531–538
Berrettini WH, Goldin LR, Martinez MM, Maxwell ME, Smith
AL, Guroff JJ, Kazuba DM, Nurnberger JI Jr, Hamovit J,
Simmons-Allings S, Muniec D, Choi H, York C, Robb AS,
Gershon ES (1991) A bipolar pedigree series for genomic
mapping of disease genes: diagnostic and analytic consider-
ations. Psychiatr Genet 2:125–160
Christian SL, McDonough J, Liu CY, Shaikh S, Vlamakis V,
Badner JA, Chakravarti A, Gershon ES (2002) An evaluation
of the assembly of an approximately 15-Mb region on hu-
man chromosome 13q32-q33 linked to bipolar disorder and
schizophrenia. Genomics 79:635–656
Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L,
Palicio M, Abderrahim H, Bougueleret L, et al (2002) Ge-
netic and physiological data implicating the new human gene
G72 and the gene for D-amino acid oxidase in schizophrenia.
Proc Natl Acad Sci USA 99:13675–13680
Cohn CK, Dunner DL, Axelrod J (1970) Reduced catechol-O-
methyltransferase activity in red blood cells of women with
primary affective disorder. Science 170:1323–1324
Cottingham RW Jr, Idury RM, Scha¨ffer AA (1993) Faster se-
quential genetic linkage computations. Am J Hum Genet 53:
252–263
Craddock N, Dave S, Greening J (2001) Association studies
of bipolar disorder. Bipolar Disord 3:284–298
Craddock N, Jones I (1999) Genetics of bipolar disorder. J
Med Genet 36:585–594
Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa
T, Goldin LR, Turner G, Rollins DY, Moses T, Sanders AR,
Karkera JD, Esterling LE, Zeng J, Ferraro TN, Guroff JJ,
Kazuba D, Maxwell ME, Nurnberger JI Jr, Gershon ES (1999)
A high-density genome scan detects evidence for a bipolar-
disorder susceptibility locus on 13q32 and other potential loci
on 1q32 and 18p11.2. Proc Natl Acad Sci USA 96:5604–
5609
Dudbridge F, Koeleman BP, Todd JA, Clayton DG (2000) Un-
biased application of the transmission/disequilibrium test to
multilocus haplotypes. Am J Hum Genet 66:2009–2012
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzan-
ti CM, Straub RE, Goldman D, Weinberger DR (2001) Ef-
fect of COMT Val108/158 Met genotype on frontal lobe func-
tion and risk for schizophrenia. Proc Natl Acad Sci USA 98:
6917–6922
Gershon ES (2000) Bipolar illness and schizophrenia as oligo-
genic diseases: implications for the future. Biol Psychiatry
47:240–244
Go¨ring HH, Terwilliger JD, Blangero J (2001) Large upward
bias in estimation of locus-specific effects from genomewide
scans. Am J Hum Genet 69:1357–1369
Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara
M, Hinokio Y, et al (2000) Genetic variation in the gene
encoding calpain-10 is associated with type 2 diabetes mel-
litus. Nat Genet 26:163–175
Kong A, Cox NJ (1997) Allele-sharing models: LOD scores
and accurate linkage tests. Am J Hum Genet 61:1179–1188
Liu C, Badner JA, Christian SL, Guroff JJ, Detera-Wadleigh SD,
Gershon ES (2001) Fine mapping supports previous linkage
evidence for a bipolar disorder susceptibility locus on 13q32.
Am J Med Genet 105:375–380
Liu C, Gershon ES (2001) “SNP-Cruncher”: a Perl script tool-
box for large-scale SNP data mining and its application on
13q32. Am J Hum Genet Suppl 69:449
Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML,
Lenane M, Robertson B, Wijsman EM, Rapoport JL, Gogos
JA, Karayiorgou M (2002) Genetic variation at the 22q11
PRODH2/DGCR6 locus presents an unusual pattern and
increases susceptibility to schizophrenia. Proc Natl Acad Sci
USA 99:3717–3722
McPeek MS, Strahs A (1999) Assessment of linkage disequilib-
rium by the decay of haplotype sharing, with application to
fine-scale genetic mapping. Am J Hum Genet 65:858–875
Niculescu AB III, Segal DS, Kuczenski R, Barrett T, Hauger
RL, Kelsoe JR (2000) Identifying a series of candidate genes
for mania and psychosis: a convergent functional genomics
approach. Physiol Genomics 4:83–91
Nurnberger JI Jr, DePaulo JR, Gershon ES, Reich T, Blehar MC,
Edenberg HJ, Foroud T, et al (1997) Genomic survey of bi-
polar illness in the NIMH Genetics Initiative pedigrees: a pre-
liminary report. Am J Med Genet 74:227–237
O’Connell JR, Weeks DE (1998) PedCheck: a program for iden-
tification of genotype incompatibilities in linkage analysis. Am
J Hum Genet 63:259–266
Ott J (1989) Computer-simulation methods in human linkage
analysis. Proc Natl Acad Sci USA 86:4175–4178
Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general
users and for biologist programmers. In: Krawetz S, Misener
S (eds) Bioinformatics methods and protocols: methods in
molecular biology. Humana Press, Totowa, NJ, pp 365–386
Sham PC, Curtis D (1995) Monte Carlo tests for associations
between disease and alleles at highly polymorphic loci. Ann
Hum Genet 59 Part 1:97–105
Shifman S, Bronstein M, Sternfeld M, Pisante´-Shalom A, Lev-
Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp
L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M,
Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak
NB, Darvasi A (2002) A highly significant association be-
tween a COMT haplotype and schizophrenia. Am J Hum
Genet 71:1296–1302
Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission
test for linkage disequilibrium: the insulin gene region and
insulin-dependent diabetes mellitus (IDDM). Am J Hum Ge-
net 52:506–516
Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S,
Sigmundsson T, Ghosh S, Brynjolfsson J, et al (2002) Neu-
regulin 1 and susceptibility to schizophrenia. Am J Hum
Genet 71:877–892
1140 Am. J. Hum. Genet. 72:1131–1140, 2003
Stine OC, McMahon FJ, Chen L, Xu J, Meyers DA, MacKinnon
DF, Simpson S, McInnis MG, Rice JP, Goate A, Reich T,
Edenberg HJ, Foroud T, Nurnberger JI Jr, Detera-Wadleigh
SD, Goldin LR, Guroff J, Gershon ES, Blehar MC, DePaulo
JR (1997) Initial genome screen for bipolar disorder in the
NIMH Genetics Initiative pedigrees: chromosomes 2, 11, 13,
14, and X. Am J Med Genet 74:263–269
Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev
MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare
AJ, Gibberman A, Wang X, O’Neill FA, Walsh D, Kendler
KS (2002) Genetic variation in the 6p22.3 gene DTNBP1,
the human ortholog of the mouse dysbindin gene, is associated
with schizophrenia. Am J Hum Genet 71:337–348
Weeks DE, Ott J, Lathrop GM (1990) SLINK: a general simula-
tion program for linkage analysis. Am J Hum Genet Suppl
47:A204
